Composition
- Active ingredients
- SODIUM BENZOATE 10%; SODIUM PHENYLACETATE 10% (5GM/50ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020645.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ammonul
- Active substance
- sodium benzoate
- Route
- Intravenous
- Dosage form
- Solution
- Applicant
- Bausch
- Status
- Discontinued
- FDA approval
- 17 Feb 2005
- Application
- NDA020645-001